NCT04271176

Brief Summary

The aim of this study is to evaluate patients with hepatic hydatidosis whose symptom at diagnosis was obstructive jaundice. As well as analyzing, the rate of performing preoperative ERCP, the results after surgery and morbidity

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

November 3, 2020

Status Verified

November 1, 2020

Enrollment Period

10 years

First QC Date

February 12, 2020

Last Update Submit

November 2, 2020

Conditions

Keywords

JaundiceEchinococcosisLiverSurgical treatment

Outcome Measures

Primary Outcomes (1)

  • Morbidity

    Postoperative morbidity after surgical treatment

    90 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated on hydatidic cyst, any surgical option

You may qualify if:

  • Hepatic Hydatidosis with obstructive jaundice surgically treated

You may not qualify if:

  • Patients with conservative treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Extremadura- Facultad de Medicina

Badajoz, 06080, Spain

Location

MeSH Terms

Conditions

Echinococcosis, HepaticJaundiceEchinococcosis

Condition Hierarchy (Ancestors)

Cestode InfectionsHelminthiasisParasitic DiseasesInfectionsLiver Diseases, ParasiticLiver DiseasesDigestive System DiseasesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and SymptomsSkin ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Department

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 17, 2020

Study Start

January 1, 2009

Primary Completion

December 31, 2018

Study Completion

April 30, 2021

Last Updated

November 3, 2020

Record last verified: 2020-11

Locations